Back to 
CAPSTONE INVESTMENT ADVISORS, LLC
CAPSTONE INVESTMENT ADVISORS, LLC
ATOS2 quarters
Position history for CAPSTONE INVESTMENT ADVISORS, LLC's holdings in ATOSSA THERAPEUTICS INC
No. Capstone Investment Advisors exited its ATOS (Atossa Therapeutics) position in Q2 2021. Its Q1 2021 13F listed 51,257 shares worth $108,000. Capstone Investment Advisors first reported ATOS in Q1 2021 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$108,000
Total Shares Change
-51,257
Quarter-by-Quarter History
Other major holders of ATOS: SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock, Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Invesco Ltd.